Understanding IL-27 Complex: Potential Drug Targets and Biomarkers

Target Name: Interleukin-27 (IL-27) Complex

NCBI ID: P31183

Interleukin-27 (IL-27) Complex

Other Name(s): IL-27 | IL-27 complex | Interleukin 27

Understanding IL-27 Complex: Potential Drug Targets and Biomarkers

Interleukin-27 (IL-27) Complex is a protein that plays a crucial role in the immune system and has been linked to a number of diseases, including autoimmune disorders, cancer, and obesity. Despite its importance, little is known about the underlying biology of IL-27 Complex, making it an attractive drug target or biomarker. In this article, we will explore the biology of IL-27 Complex and its potential as a drug target.

The IL-27 Complex is a protein complex that consists of several subunits, including IL-27A, IL-27B, IL-27C, and IL-27D. These subunits are held together by disulfide bonds and form a monomeric complex. The IL- 27A subunit is the primary receptor for IL-27, and it is expressed in various tissues throughout the body, including the skin, gut, and lymphoid organs. The IL-27B subunit is a scaffold protein that helps to maintain the structure of the IL -27 complex. The IL-27C subunit is a type of transmembrane protein that is involved in the regulation of ion channels and is expressed in the brain and other tissues. The IL-27D subunit is a cytoplasmic protein that is involved in the regulation of cell adhesion and is expressed in various tissues, including the placenta and the liver.

The biology of IL-27 Complex is complex and involves multiple signaling pathways. One of the most well-established signaling pathways involves the T cell signaling pathway. T cells are a critical part of the immune system and play a crucial role in fighting off infections and cancer. IL-27 is involved in the regulation of T cell development, activation, and differentiation. Studies have shown that IL-27 can promote the growth and survival of naive T cells and can also stimulate the production of memory T cells.

Another signaling pathway that is involved in the IL-27 Complex is the production of pro-inflammatory cytokines. These cytokines, such as TNF-伪, IL-1尾, and IL-6, are involved in the regulation of inflammation and immune responses. The IL-27 Complex is involved in the production of these cytokines and can also be regulated by them. For example, the production of IL-6 by the IL-27 Complex is regulated by the cytokine PD-1.

IL-27 is also involved in the regulation of cellular processes that are important for the development and maintenance of cancer. For example, the IL-27 Complex has been shown to promote the growth and survival of various cancer cell types, including breast, lung , and ovarian cancer cells. The role of IL-27 in cancer development is still not well understood, but it is possible that it may play a negative role in the regulation of tumor progression and the development of resistance to chemotherapy.

In addition to its role in cancer development, IL-27 is also involved in the regulation of autoimmune disorders. The IL-27 Complex has been shown to promote the production of immune cells, including T cells and B cells, which are involved in the regulation of autoimmune responses. The production of IL-27 by the immune cells is regulated by various cytokines, including IL-10 and IL-12.

The potential drug targets for IL-27 Complex are numerous and varied. One of the most promising targets is the use of IL-27 inhibitors to treat autoimmune disorders. The use of IL-27 inhibitors has been shown to be effective in treating a variety of autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. In addition to the use of IL-27 inhibitors, another potential drug target for IL-27

Protein Name: Interleukin-27 (IL-27) Complex

The "Interleukin-27 (IL-27) Complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Interleukin-27 (IL-27) Complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets